Higher circulating levels of fetuin-A have been linked to obesity (206) and its related conditions, including type 2 diabetes (207), metabolic syndrome (201, 206), PCOS (208) (209), and NAFLD (200). This evidence concerns the gene AHSG and polycystic ovary syndrome.